Polar Pharma India Ltd
Polar Pharma India Limited is an India-based company. The Company is engaged in dealing with latex prophylactics.
- Market Cap ₹ Cr.
- Current Price ₹ 0.82
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -78.9
- Dividend Yield 0.00 %
- ROCE -0.88 %
- ROE %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 155 to 58.8 days.
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|
| 19 | 26 | 0 | 0 | 11 | |
| 24 | 26 | 11 | 2 | 9 | |
| Operating Profit | -5 | -1 | -11 | -2 | 2 |
| OPM % | -25% | -2% | -4,108% | -6,500% | 18% |
| -2 | 1 | -42 | 0 | 0 | |
| Interest | 5 | 5 | 4 | 12 | 13 |
| Depreciation | 3 | 2 | 2 | 2 | 2 |
| Profit before tax | -14 | -7 | -59 | -16 | -14 |
| Tax % | -33% | -62% | 15% | 0% | 0% |
| -9 | -3 | -68 | -16 | -14 | |
| EPS in Rs | -7.43 | -2.21 | -55.42 | -13.09 | -11.03 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -25% |
| TTM: | 36100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 |
| Reserves | -9 | -12 | -80 | -96 | -109 |
| 46 | 43 | 86 | 105 | 119 | |
| 12 | 10 | 13 | 8 | 10 | |
| Total Liabilities | 62 | 53 | 32 | 29 | 32 |
| 31 | 29 | 26 | 24 | 22 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 30 | 25 | 6 | 5 | 10 | |
| Total Assets | 62 | 53 | 32 | 29 | 32 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|
| -6 | 6 | -41 | 2 | -1 | |
| 1 | 1 | 0 | 0 | -0 | |
| 4 | -6 | 39 | -2 | 1 | |
| Net Cash Flow | -2 | 1 | -1 | -0 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | |
|---|---|---|---|---|---|
| Debtor Days | 190 | 90 | 42 | 365 | 59 |
| Inventory Days | 458 | 83 | 110 | 4,198 | 365 |
| Days Payable | 53 | 20 | 136 | 20,622 | 370 |
| Cash Conversion Cycle | 596 | 153 | 16 | -16,060 | 54 |
| Working Capital Days | 264 | 67 | -10,697 | -37,352 | -8 |
| ROCE % | -4% | -35% | -21% | -1% |
Documents
Announcements
No data available.